451 related articles for article (PubMed ID: 15673769)
1. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
[TBL] [Abstract][Full Text] [Related]
2. Emergence of clindamycin-resistant Streptococcus pyogenes isolates obtained from patients with severe invasive infections in Japan.
Ikebe T; Wada A; Oguro Y; Ogata K; Katsukawa C; Isobe J; Shima T; Suzuki R; Ohya H; Tominaga K; Okuno R; Uchitani Y; Watanabe H;
Jpn J Infect Dis; 2010 Jul; 63(4):304-5. PubMed ID: 20657078
[No Abstract] [Full Text] [Related]
3. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
Schoening TE; Wagner J; Arvand M
Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
[TBL] [Abstract][Full Text] [Related]
4. T serotypes and antimicrobial susceptibilities of group A streptococcus isolates from pediatric pharyngotonsillitis.
Funahashi K; Nakane K; Yasuda N; Suzuki M; Narita A; Arai N; Ahn J; Koyama N; Ushida H; Nishimura N; Ozaki T
Jpn J Infect Dis; 2008 Nov; 61(6):454-6. PubMed ID: 19050353
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
Gracia M; Díaz C; Coronel P; Gimeno M; García-Rodas R; Rodríguez-Cerrato V; del Prado G; Huelves L; Ruiz V; Naves PF; Ponte MC; Granizo JJ; Soriano F
Diagn Microbiol Infect Dis; 2009 May; 64(1):52-6. PubMed ID: 19232860
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
Orscheln RC; Johnson DR; Olson SM; Presti RM; Martin JM; Kaplan EL; Storch GA
J Infect Dis; 2005 Apr; 191(8):1272-9. PubMed ID: 15776373
[TBL] [Abstract][Full Text] [Related]
8. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
[TBL] [Abstract][Full Text] [Related]
9. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
10. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotic sensitivity of strains of group A beta-hemolytic streptococci isolated recently].
Alós JI; González-Palacios R; Cuadros JA; Escobar JC
Med Clin (Barc); 1990 Jan; 94(1):12-4. PubMed ID: 2186225
[TBL] [Abstract][Full Text] [Related]
12. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
13. Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.
Capoor MR; Nair D; Deb M; Batra K; Aggarwal P
Jpn J Infect Dis; 2006 Oct; 59(5):334-6. PubMed ID: 17060703
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
15. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
17. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
Sakran W; Raz R; Colodner R; Keness Y
Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
[TBL] [Abstract][Full Text] [Related]
18. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus.
Dipersio LP; Dipersio JR
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):189-93. PubMed ID: 16989973
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
Kaya EG; Yücel M; Karakoç AE
Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
[TBL] [Abstract][Full Text] [Related]
20. Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus.
Koliou M; Ioannou Y; Efstratiou A; Hannidou N; Pieri V; Alexandrou M; Soteriades ES
Clin Microbiol Infect; 2007 Jun; 13(6):645-7. PubMed ID: 17378928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
